ARCHIVES

Platinum-Free Break Enhances Therapy After First Relapse In Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 26 No. 3 | March 28, 2003

Download PDF Visit The Full Archive

Related Articles

NSABP’s B-14 Study Reports Deaths From Uterine Cancer Related To Tamoxifen

February 25, 1994

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

January 26, 2001

Many Colorectal Cancer Survivors Do Not Receive Recommended Follow-up Care

September 26, 2008

Fewer New Grants Funded Under President’s Proposal.

February 11, 2000

Joint NCI/FDA Program approved; ‘May Solve Our Differences’

December 15, 1989

NCI Chips In $2 Million For AACR Meeting; Advisors, Senior Staff Not Consulted.

June 20, 2003